S. Shalimar

Identification of plasma lipids as non-invasive signatures for metabolic dysfunction-associated steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the leading cause of chronic liver diseases worldwide, which may progress to cirrhosis and hepatocellular carcinoma (HCC). To address this growing public health concern, non-invasive diagnostic approa...